Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
China flag China · Delayed Price · Currency is CNY
8.02
-0.04 (-0.50%)
Sep 4, 2026, 3:00 PM CST

SHA:600867 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,3151,434590.21,104788.06865.04
Trading Asset Securities
6863.2255.455.5258.4637
Cash & Short-Term Investments
1,3831,497645.61,160846.52902.04
Cash Growth
18.71%131.89%-44.33%37.00%-6.15%21.28%
Accounts Receivable
456483.16547.57869.74455.99650.94
Other Receivables
33.6810.527.888.7920.567.63
Receivables
489.69493.69555.45878.53476.55658.57
Inventory
667.91704.22736.31705.35653.9537.92
Prepaid Expenses
----0.020.03
Other Current Assets
87.8251.7672.5672.7679.4363.9
Total Current Assets
2,6282,7472,0102,8162,0562,162
Property, Plant & Equipment
2,4472,5372,7322,6712,6782,392
Long-Term Investments
617.18569.27627.75435.01362.49457.91
Other Intangible Assets
544.11547.98628.05670.02487.01389.07
Long-Term Deferred Tax Assets
59.4266.35142.9138.5546.1942.41
Long-Term Deferred Charges
1,2551,152977.32690.91607.25447.29
Other Long-Term Assets
279.12286.97264.08449.84513.13628.85
Total Assets
7,8307,9067,3827,7716,7506,520

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
96.0891.196.71115.980.8675
Accrued Expenses
5.9319.5751.9530.9311.0331.74
Short-Term Debt
282.7633.02416.76150--
Current Portion of Long-Term Debt
142.95266.75----
Current Portion of Leases
-8.594.4---
Current Income Taxes Payable
38.371.710.0852.46-80.45
Current Unearned Revenue
8.128.7216.0710.4821.087.89
Other Current Liabilities
149.77116.0480.68160.3949.0873.47
Total Current Liabilities
723.98545.51666.65520.16162.05268.55
Long-Term Debt
220.75192.19253.49-2.652.65
Long-Term Leases
34.1725.3319.5---
Long-Term Unearned Revenue
27.8128.4127.6627.5128.5328.67
Long-Term Deferred Tax Liabilities
7.557.411.997.417.51-
Total Liabilities
1,014798.84979.29555.08200.74299.87

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,9591,9591,9821,9941,9942,034
Additional Paid-In Capital
328.89301.67509.32622.56641.91,006
Retained Earnings
4,6204,9204,1874,7254,0533,567
Treasury Stock
-83.54-88.11-300.28-134.83-150.37-398.13
Comprehensive Income & Other
10.6710.676.915.286.396.94
Total Common Equity
6,8357,1036,3857,2116,5446,215
Minority Interest
-19.434.4217.965.095.315.35
Shareholders' Equity
6,8157,1086,4037,2166,5506,220
Total Liabilities & Equity
7,8307,9067,3827,7716,7506,520

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
680.62525.89694.151502.652.65
Net Cash (Debt)
702.06971.17-48.551,010843.87899.39
Net Cash Growth
143.87%--19.65%-6.17%21.36%
Net Cash Per Share
0.360.49-0.020.510.420.44
Filing Date Shares Outstanding
1,8291,9561,7541,9161,9842,018
Total Common Shares Outstanding
1,8291,9561,7541,9161,9842,018
Working Capital
1,9042,2011,3432,2961,8941,894
Book Value Per Share
3.743.633.643.763.303.08
Tangible Book Value
6,2916,5555,7576,5416,0575,826
Tangible Book Value Per Share
3.443.353.283.413.052.89
Buildings
-1,8201,8291,4371,4521,305
Machinery
-2,3752,3561,5321,5911,301
Construction In Progress
-169.5226.111,3191,1581,203